TriSalus Life Sciences, Inc.
3 clinical trials · Sponsor
◉ Watch TriSalus Life Sciences, Inc.
| Record | Firm | Date |
|---|---|---|
| Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma (NCT05607953) | TriSalus Life Sciences, Inc. | 2023-03-01 |
| Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors (NCT05220722) | TriSalus Life Sciences, Inc. | 2022-03-02 |
| Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma (NCT04935229) | TriSalus Life Sciences, Inc. | 2021-08-02 |
Track TriSalus Life Sciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.